Moderna (MRNA) Exceeds Market Returns: Some Facts to Consider

Moderna (MRNA) Exceeds Market Returns: Some Facts To Consider

3 weeks from now

Oct 29, 2024  · MRNA's full-year Zacks Consensus Estimates are calling for earnings of -$9.88 per share and revenue of $3.2 billion. These results would represent year-over-year changes of …

yahoo.com

Moderna (MRNA) Exceeds Market Returns: Some Facts To Consider

3 weeks from now

Oct 29, 2024  · Moderna (MRNA) closed the latest trading day at $55.22, indicating a +0.77% change from the previous session's end. This change outpaced the S&P 500's 0.16% gain on …

nasdaq.com

Moderna (MRNA) Exceeds Market Returns: Some Facts To Consider

3 weeks from now

Oct 29, 2024  · In the most recent trading session, Moderna (MRNA) closed at $55.22, indicating a +0.77% shift from the previous trading day. Moderna (MRNA) Exceeds Market Returns: Some …

zacks.com

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth …

3 weeks from now

Apr 26, 2024  · Moderna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous trading session. The stock outperformed the S&P 500, which registered a …

nasdaq.com

Moderna (MRNA) Rises But Trails Market: What Investors Should …

3 weeks from now

In the latest trading session, Moderna (MRNA) closed at $42.18, marking a +0.43% move from the previous day. This change lagged the S&P 500's 1.26% gain on the day. Elsewhere, the …

yahoo.com

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth …

3 weeks from now

In the latest market close, Moderna (MRNA) reached $137.60, with a +0.44% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily …

nasdaq.com

Moderna (MRNA) Exceeds Market Returns: Some Facts To …

3 weeks from now

Oct 29, 2024  · Moderna (MRNA) closed the latest trading day at $55.22, indicating a +0.77% change from the previous session's end. This change outpaced the S&P 500's 0.16% gain on …

tradingview.com

Moderna (MRNA) Rises Higher Than Market: Key Facts

3 weeks from now

Sep 30, 2024  · Moderna (MRNA) closed at $66.83 in the latest trading session, marking a +1.64% move from the prior day. This change outpaced the S&P 500's 0.42% gain on the day. …

nasdaq.com

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

3 weeks from now

Nov 7, 2024  · Cambridge, Mass.-based Moderna (MRNA) had a net profit of $13 million, or 3 cents a share, for the quarter, after a loss of $3.6 billion, or $9.53 a share, in the year-earlier …

morningstar.com

Moderna (MRNA) Rises But Trails Market: What Investors Should …

3 weeks from now

Jan 3, 2025  · In the latest trading session, Moderna (MRNA Quick Quote MRNA - Free Report) closed at $42.18, marking a +0.43% move from the previous day. This change lagged the S&P …

zacks.com

Moderna's MRNA Technology Looks Undervalued Despite Lower …

3 weeks from now

Jan 14, 2025  · Moderna's massive covid vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, but that balance is steadily shrinking due to previous share …

morningstar.com

Moderna (MRNA) Rises Higher Than Market: Key Facts

3 weeks from now

Sep 16, 2024  · Moderna (MRNA) closed the most recent trading day at $69.17, moving +1.3% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.13%. On …

nasdaq.com

Is Moderna A Bad-News Buy For 2025? - MSN

3 weeks from now

At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from a September forecast of $2.5 billion to $3.5 billion. And …

msn.com

Moderna (MRNA) Increases Despite Market Slip: Here's What You …

3 weeks from now

4 days ago  · Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a …

nasdaq.com

Moderna's Revenue Warning Sends The Stock Into The Red For 2024

3 weeks from now

Aug 1, 2024  · The guidance came as Moderna reported a second quarter loss of $3.33 per share, and revenue fell 30% to $241 million. Sales of its Spikevax COVID-19 shot slumped 39% to …

investopedia.com

Moderna (MRNA) Stock Drops Despite Market Gains: Important …

3 weeks from now

Oct 8, 2024  · Moderna (MRNA) closed at $58.39 in the latest trading session, marking a -0.56% move from the prior day. The stock's performance was behind the S&P 500's daily gain of …

nasdaq.com